Advanced search
7 files | 5.50 MB Add to list
Author
Organization
Project
Abstract
Objectives - Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an increasing incidence and prevalence due to progressively ageing populations. Costs related to AF are both direct and indirect. This systematic review aims to identify the main cost drivers of the illness, assess the potential economic impact resulting from changes in care strategies and propose interventions where they are most needed. Methods - A systematic literature search of the PubMed and Scopus databases was performed to identify analytical observational studies defining the cost of illness in cases of AF. The search strategy was based on the PRISMA 2020 recommendations. Results - Of the 944 articles retrieved, 24 met the inclusion criteria. These studies were conducted in several countries. All studies calculated the direct medical costs, while 8 out of 24 studies assessed indirect costs. The median annual direct medical cost per patient, considering all studies, was €9,409 (13,333 US dollars in purchasing power parities), with a very large variability due to the heterogeneity of different analyses. Hospitalisation costs are generally the main cost drivers. Comorbidities and complications, such as stroke, considerably increase the average annual direct medical cost of AF. Conclusions - In most of the analysed studies, inpatient care cost represents the main component of the mean direct medical cost per patient. Stroke and heart failure are responsible for a large share of the total costs; therefore, implementing guidelines to manage comorbidities in AF is a necessary step to improve health and mitigate healthcare costs.
Keywords
Atrial fibrillation, Cost of illness, Direct costs, Indirect costs, Comorbidities

Downloads

  • 0 Unblinded title page.docx
    • colophon/title page
    • |
    • open access
    • |
    • Word
    • |
    • 20.71 KB
  • Supplementary material.docx
    • supplementary material
    • |
    • open access
    • |
    • Word
    • |
    • 83.47 KB
  • Figure 1.tif
    • supplementary material
    • |
    • open access
    • |
    • image/tiff
    • |
    • 589.18 KB
  • Figure 2.tif
    • supplementary material
    • |
    • open access
    • |
    • image/tiff
    • |
    • 867.41 KB
  • Figure 3.tif
    • supplementary material
    • |
    • open access
    • |
    • image/tiff
    • |
    • 1.10 MB
  • Figure 4.tif
    • supplementary material
    • |
    • open access
    • |
    • image/tiff
    • |
    • 983.53 KB
  • published version.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 1.85 MB

Citation

Please use this url to cite or link to this publication:

MLA
Buja, Alessandra, et al. “The Cost of Atrial Fibrillation : A Systematic Review.” VALUE IN HEALTH, vol. 27, no. 4, 2024, pp. 527–41, doi:10.1016/j.jval.2023.12.015.
APA
Buja, A., Rebba, V., Montecchio, L., Renzo, G., Baldo, V., Cocchio, S., … Lip, G. (2024). The cost of atrial fibrillation : a systematic review. VALUE IN HEALTH, 27(4), 527–541. https://doi.org/10.1016/j.jval.2023.12.015
Chicago author-date
Buja, Alessandra, Vincenzo Rebba, Laura Montecchio, Giulia Renzo, Vincenzo Baldo, Silvia Cocchio, Nicola Ferri, et al. 2024. “The Cost of Atrial Fibrillation : A Systematic Review.” VALUE IN HEALTH 27 (4): 527–41. https://doi.org/10.1016/j.jval.2023.12.015.
Chicago author-date (all authors)
Buja, Alessandra, Vincenzo Rebba, Laura Montecchio, Giulia Renzo, Vincenzo Baldo, Silvia Cocchio, Nicola Ferri, Federico Migliore, Alessandro Zorzi, Brendan Collins, Cheïma Amrouch, Delphine De Smedt, Christodoulos Kypridemos, Mirko Petrovic, Martin O’Flaherty, and Gregory Lip. 2024. “The Cost of Atrial Fibrillation : A Systematic Review.” VALUE IN HEALTH 27 (4): 527–541. doi:10.1016/j.jval.2023.12.015.
Vancouver
1.
Buja A, Rebba V, Montecchio L, Renzo G, Baldo V, Cocchio S, et al. The cost of atrial fibrillation : a systematic review. VALUE IN HEALTH. 2024;27(4):527–41.
IEEE
[1]
A. Buja et al., “The cost of atrial fibrillation : a systematic review,” VALUE IN HEALTH, vol. 27, no. 4, pp. 527–541, 2024.
@article{01HNDG6PVSXCXDSNMZXE56XJWD,
  abstract     = {{Objectives - Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an increasing incidence and prevalence due to progressively ageing populations. Costs related to AF are both direct and indirect. This systematic review aims to identify the main cost drivers of the illness, assess the potential economic impact resulting from changes in care strategies and propose interventions where they are most needed. 
Methods - A systematic literature search of the PubMed and Scopus databases was performed to identify analytical observational studies defining the cost of illness in cases of AF. The search strategy was based on the PRISMA 2020 recommendations. 
Results - Of the 944 articles retrieved, 24 met the inclusion criteria. These studies were conducted in several countries. All studies calculated the direct medical costs, while 8 out of 24 studies assessed indirect costs. The median annual direct medical cost per patient, considering all studies, was €9,409 (13,333 US dollars in purchasing power parities), with a very large variability due to the heterogeneity of different analyses. Hospitalisation costs are generally the main cost drivers. Comorbidities and complications, such as stroke, considerably increase the average annual direct medical cost of AF.
Conclusions - In most of the analysed studies, inpatient care cost represents the main component of the mean direct medical cost per patient. Stroke and heart failure are responsible for a large share of the total costs; therefore, implementing guidelines to manage comorbidities in AF is a necessary step to improve health and mitigate healthcare costs.}},
  author       = {{Buja, Alessandra and Rebba, Vincenzo and Montecchio, Laura and Renzo, Giulia and Baldo, Vincenzo and Cocchio, Silvia and Ferri, Nicola and Migliore, Federico and Zorzi, Alessandro and Collins, Brendan and Amrouch, Cheïma and De Smedt, Delphine and Kypridemos, Christodoulos and Petrovic, Mirko and O’Flaherty, Martin and Lip, Gregory}},
  issn         = {{1098-3015}},
  journal      = {{VALUE IN HEALTH}},
  keywords     = {{Atrial fibrillation,Cost of illness,Direct costs,Indirect costs,Comorbidities}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{527--541}},
  title        = {{The cost of atrial fibrillation : a systematic review}},
  url          = {{http://doi.org/10.1016/j.jval.2023.12.015}},
  volume       = {{27}},
  year         = {{2024}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: